Romanian male patients with the dual diagnosis of schizophrenia and alcohol use disorder: a prospective study of clinical, social, and treatment-related factors affecting quality of life - Report - MDSpire

Romanian male patients with the dual diagnosis of schizophrenia and alcohol use disorder: a prospective study of clinical, social, and treatment-related factors affecting quality of life

  • By

  • Antonia Ioana Vasile

  • Simona Trifu

  • Cristina Alexandra Negoita

  • May 13, 2026

  • 0 min

Share

Clinical Report: Quality of Life in Romanian Males with Schizophrenia and AUD

Overview

This study investigates the factors influencing quality of life (QoL) in Romanian males diagnosed with schizophrenia and alcohol use disorder (AUD). Key findings indicate that self-care capacity, social support, and educational level significantly predict QoL outcomes over a six-month period.

Background

Schizophrenia often co-occurs with alcohol use disorder, leading to worsened clinical outcomes and diminished quality of life. Understanding the interplay of clinical, social, and treatment factors is crucial for improving patient care and recovery strategies. This study highlights the need for a multidimensional approach to treatment that addresses both mental health and substance use issues.

Data Highlights

FactorAssociation with QoL
Self-care capacityPositive
Social supportPositive
Educational levelPositive
Antipsychotic treatment needNegative
Alcohol use severityNo independent association

Key Findings

  • Higher self-care capacity and social support are linked to better QoL.
  • Educational level positively predicts QoL at follow-up.
  • The need for antipsychotic treatment correlates with lower QoL.
  • Negative and general psychopathology are associated with poorer QoL outcomes.
  • Alcohol use severity does not independently affect QoL in this population.

Clinical Implications

Clinicians should focus on enhancing self-care and social support systems for patients with dual diagnoses of schizophrenia and AUD. Integrated treatment approaches that include anti-craving medications may improve long-term QoL outcomes.

Conclusion

The findings underscore the importance of addressing both clinical and social factors in the management of patients with schizophrenia and AUD to enhance their quality of life. A comprehensive, recovery-oriented approach is essential for effective treatment.

Related Resources & Content

  1. Drugs - Real World Outcomes, Monthly Long-Acting Injectable Aripiprazole for Schizophrenia Patients with Concurrent Substance Use Disorders: Findings from a Multicenter Observational Study
  2. BMC Psychiatry (Springer), Longitudinal Analysis of Recovery Domains in Patients with Schizophrenia Spectrum Disorders: Findings from a Six-Year Follow-Up Study
  3. BMC Psychiatry (Springer), Prognostic Assessment of Schizophrenia Utilizing the Anderson-Gill Time-Dependent Cox Model: A Cohort Analysis from a Developing Area in Southwest China
  4. BMC Psychiatry (Springer), A qualitative study of patient’s experiences of receiving alcohol interventions according to the 15-method in psychiatric care
  5. Alcohol use disorder exacerbates clinical and vascular risks differentially in psychiatric disorders - ScienceDirect
  6. NYSDOH AI Treatment of Alcohol Use Disorder
  7. INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia
  8. Alcohol use disorder exacerbates clinical and vascular risks differentially in psychiatric disorders - ScienceDirect
  9. NYSDOH AI Treatment of Alcohol Use Disorder
  10. INTEGRATE: international guidelines for the algorithmic treatment of schizophrenia

Original Source(s)

Related Content